Financials Pangenomic Health Inc.
Equities
NARA
CA69842E3041
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | 0.00% | -25.00% | -55.00% |
02-19 | PanGenomic Health plans to withdraw shares from Aquis Stock Exchange | AN |
02-16 | Pangenomic Health Inc. Announces Changes to Board of Directors | CI |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 19.99 |
Enterprise Value (EV) 1 | 20 |
P/E ratio | -1.23 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | -5,609,164 x |
EV / FCF | -14,230,361 x |
FCF Yield | -0% |
Price to Book | -118 x |
Nbr of stocks (in thousands) | 7,403 |
Reference price 2 | 2.700 |
Announcement Date | 01/05/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales | - | - | - | - |
EBITDA | - | - | -0.8475 | -3.566 |
EBIT 1 | -0.000072 | -0.1349 | -0.8496 | -3.577 |
Operating Margin | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.003438 | -0.14 | -2.649 | -11.99 |
Net income 1 | -0.003438 | -0.14 | -2.649 | -11.99 |
Net margin | - | - | - | - |
EPS 2 | -0.005857 | -0.2385 | -1.339 | -2.189 |
Free Cash Flow | - | -0.0864 | -0.4715 | -1.406 |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 28/03/22 | 28/03/22 | 01/05/23 | 01/05/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net Debt 1 | - | - | - | 0.01 |
Net Cash position 1 | 0 | 0.01 | 1.35 | - |
Leverage (Debt/EBITDA) | - | - | - | -0.003714 x |
Free Cash Flow | - | -0.09 | -0.47 | -1.41 |
ROE (net income / shareholders' equity) | - | -2,091% | -235% | -1,183% |
ROA (Net income/ Total Assets) | - | -110% | -39% | -145% |
Assets 1 | - | 0.1269 | 6.796 | 8.265 |
Book Value Per Share 2 | 0 | 0.0200 | 0.4900 | -0.0200 |
Cash Flow per Share 2 | 0 | 0.0700 | 0.3800 | 0.0100 |
Capex | - | - | 0.01 | 0.01 |
Capex / Sales | - | - | - | - |
Announcement Date | 28/03/22 | 28/03/22 | 01/05/23 | 01/05/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-55.00% | 694K | |
+17.56% | 8.09B | |
+31.59% | 4.3B | |
-30.67% | 2.63B | |
-18.34% | 1.41B | |
-26.12% | 1.31B | |
-33.58% | 1.15B | |
+11.82% | 1B | |
-33.89% | 924M | |
-20.77% | 676M |
- Stock Market
- Equities
- NARA Stock
- Financials Pangenomic Health Inc.